Seven McMaster-led research projects are receiving funding from the Clinical Trials Fund, designed to enhance Canada’s clinical trials ecosystem from discovery to implementation.
Much has been made recently about the new antiviral drug remdesivir for COVID-19 patients, but a McMaster University-led guideline for physicians warns that it would only be used in the most serious cases, and more research is needed.